Skip to content

E-health in incontinence: from U-Pad to I-Pad

E-health in incontinence: from U-Pad to I-Pad - E-health in incontinence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46957
Enrollment
292
Registered
2015-05-12
Start date
2015-10-08
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence urinary leakage

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Women, 18 years or older; - Having access to mobile Apps on smartphone or tablet (Apple or Android platform) * wifi entrance to the internet is sufficient; - Urinary incontinence (UI), defined as any involuntary loss of urine according to the definition of the International Consultation on Incontinence (ICI), regardless of the subtype (stress UI, urgency UI or mixed type UI). Incontinence episodes should be twice a week or more; - Wish to be treated; - Written informed consent.

Exclusion criteria

Exclusion criteria: - Indwelling urinary catheter; - Urogenital malignancy; - Previous urethral surgery; - Being treated for UI in the previous year (pharmacologically or non-pharmacologically); - Terminally or seriously ill; according to the GP of the patient - Cognitive impairment or psychiatric disorder; - Urinary tract infection (dipstick and if negative, dipslide or urine culture); - Overflow or continuous urinary incontinence; - Pregnancy or recent childbirth (

Design outcomes

Primary

MeasureTime frame
The primary outcome is the score on the International Consultation on Incontinence Questionnaire on UI Short Form (ICIQ-UI-SF), which measures symptoms and impact of the UI on daily life.

Secondary

MeasureTime frame
Secondary outcomes are the perception of improvement by the patient, number of UI episodes, condition- specific and generic health related quality of life, sexual functioning and costs. Facilitators and barriers for the implementation of the intervention.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)